CRBN and myelodysplastic syndrome: Amongst these CRBN neosubstrates, CK1α is ubiquitinated and degraded in the presence of lenalidomide, which leads to attenuation of the growth of myelodysplastic syndrome with deletion of chromosome 5q (16).